Cargando…
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
The most important goals for the field of immuno-oncology are to improve the response rate and increase the number of tumor indications that respond to immunotherapy, without increasing adverse side effects. One approach to achieve these goals is to use tumor-directed immunotherapy, i.e., to focus t...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222923/ https://www.ncbi.nlm.nih.gov/pubmed/27714433 http://dx.doi.org/10.1007/s00262-016-1909-3 |